PEPG

PepGen Inc.

14.08 USD
+0.43 (+3.15%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

PepGen Inc. stock is up 104.65% since 30 days ago. The next earnings date is Mar 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 1 February’s closed higher than January. 100% of analysts rate it a buy.

About PepGen Inc.

PepGen Inc. focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy.